Sort
48,018 grants matching “immunotherapy”
Molecular Determinants of Hemogenic Endothelium
$495,137Igor I Slukvin · University Of Wisconsin-Madison · R01 · FY2019 · HL
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
$495,129Dai Fukumura · Massachusetts General Hospital · R01 · FY2017 · CA
Macrophages as modulators of T cell function and therapeutic response in clear cell renal cell carcinoma
$495,125Abraham Ari Hakimi · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Gain-of-function complement activators as a new class of immunotherapeutic molecules
$495,105Ruben Martinez Barricarte · Vanderbilt University Medical Center · R01 · FY2025 · CA
Gain-of-function complement activators as a new class of immunotherapeutic molecules
$495,105Ruben Martinez Barricarte · Vanderbilt University Medical Center · R01 · FY2023 · CA
Administrative Core
$495,090Haifa Shen · Methodist Hospital Research Institute · U54 · FY2018 · CA
Developmental Funds
$495,052Robert B. Diasio · Mayo Clinic Rochester · P30 · FY2019 · CA
Clinical trials employing cancer vaccine combination therapies
$494,990James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$494,990James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
IN VIVO TREATMENT OF EAE WITH ANTI I-A ANTIBODIES
$494,981Stanford University · R01 · FY2001 · NS
Ultra-Bright Fluorescent Probes for Flow Cytometry
$494,939Jiangbo Yu · Lamprogen, Inc. · R44 · FY2018 · GM
Ultra-Bright Fluorescent Probes for Flow Cytometry
$494,939Jiangbo Yu · Lamprogen, Inc. · R44 · FY2019 · GM
ANTIVIRAL &ANTIFIBROTIC LIVER THERAPY OF HCV+ DRINKERS
$494,892Mount Sinai School Of Medicine Of Nyu · R01 · FY2002 · AA
Enhanced Viro-Immunotherapy for Breast Cancer Brain Metastasis
$494,886Ji Young Yoo · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · CA
Therapeutically harnessing anti-viral resident memory T cells in solid tumors
$494,877Pamela Rosato · Dartmouth College · R01 · FY2025 · CA
Translational Immunology
$494,832Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Rare Central Nervous System Cancers Initiative
$494,832Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Administrative Core
$494,804Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2017 · CA
Peptide-mediated immunotherapy of KSHV-associated malignancy.
$494,752Jae U Jung · University Of Southern California · RC1 · FY2009 · CA
Genetically Modified Gamma Delta T Cells to Target SIV Reservoirs
$494,712Namita Rout · Tulane University Of Louisiana · R33 · FY2022 · AI
Predictors of clinical outcome after therapeutic vaccination in follicular lympho
$494,701Sattva S Neelapu · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
Predictors of clinical outcome after therapeutic vaccination in follicular lympho
$494,701Sattva S Neelapu · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
Role of Neutralizing Antibodies in Transmission of SHIV
$494,682Nancy Logan Haigwood · Seattle Biomedical Research Institute · R01 · FY2006 · HD
Controllable In Vivo Genome Editing for Immune-Checkpoint Blockade in Solid Tumors
$494,605Sheng Tong · University Of Kentucky · R01 · FY2022 · EB
Investigational Cancer Therapeutics Training Program
$494,599Mark G Kris · Sloan-Kettering Inst Can Research · T32 · FY2017 · CA